Overview

Influence of CYP2C19 Genotype on the Pharmacokinetics (PK) of Voriconazole

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to: - Evaluate the influence of CYP2C19 genotype on PK profiles of voriconazole.
Phase:
Phase 1
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Voriconazole